Horizon Europe: towards a European agenda for global health research and innovation

Ibrahim Abubakar; Antoni Plasencia; Till Bärnighausen; Guenter Froeschl; Matthew Burton; Frank Cobelens

doi:https://doi.org/10.1016/S0140-6736(19)30287-9

Horizon Europe: towards a European agenda for global health research and innovation

Ibrahim Abubakar, Antoni Plasencia, Till Bärnighausen, Guenter Froeschl, Matthew Burton, Frank Cobelens

Research output: Contribution to journal › Comment/Letter to the editor › Academic

5 Citations (Scopus)

Original language	English
Pages (from-to)	1272-1273
Number of pages	2
Journal	The Lancet
Volume	393
Issue number	10178
DOIs	https://doi.org/10.1016/S0140-6736(19)30287-9
Publication status	Published - 30 Mar 2019

Access to Document

https://doi.org/10.1016/S0140-6736(19)30287-9

Cite this

@article{f46fcba91273482092590e239954f98b,

title = "Horizon Europe: towards a European agenda for global health research and innovation",

author = "Ibrahim Abubakar and Antoni Plasencia and Till B{\"a}rnighausen and Guenter Froeschl and Matthew Burton and Frank Cobelens",

note = "Funding Information: We all hold leadership positions in global health institutes in Europe and could benefit from increased global health funding through the EU. IA, MB, AP, and TB currently receive funding from the EU's research programmes. We declare no other competing interests",

year = "2019",

month = mar,

day = "30",

doi = "https://doi.org/10.1016/S0140-6736(19)30287-9",

language = "English",

volume = "393",

pages = "1272--1273",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10178",

}

TY - JOUR

T1 - Horizon Europe

T2 - towards a European agenda for global health research and innovation

AU - Abubakar, Ibrahim

AU - Plasencia, Antoni

AU - Bärnighausen, Till

AU - Froeschl, Guenter

AU - Burton, Matthew

AU - Cobelens, Frank

N1 - Funding Information: We all hold leadership positions in global health institutes in Europe and could benefit from increased global health funding through the EU. IA, MB, AP, and TB currently receive funding from the EU's research programmes. We declare no other competing interests

PY - 2019/3/30

Y1 - 2019/3/30

UR - http://www.scopus.com/inward/record.url?scp=85063342135&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S0140-6736(19)30287-9

DO - https://doi.org/10.1016/S0140-6736(19)30287-9

M3 - Comment/Letter to the editor

C2 - 30938305

SN - 0140-6736

VL - 393

SP - 1272

EP - 1273

JO - The Lancet

JF - The Lancet

IS - 10178

ER -

Horizon Europe: towards a European agenda for global health research and innovation

Access to Document

Other files and links

Cite this